KMID : 0390219990100020211
|
|
Journal of Clinical Otolaryngology, Head and Neck Surgery 1999 Volume.10 No. 2 p.211 ~ p.216
|
|
Pain Control after Nasal Surgery
|
|
±èÇö¿õ/Hyun Ung Kim
±èŸ¸/¹®»ó¿ì/À̽¼ö/À̼º¹Î/ÀÌ¿ëÈÆ/ÀÓ¿µÃ¢/ÀÌÁ¤±Ç/Tae Man Him/Sang Woo Moon/Seung Soo Lee/Sung Min Lee/Yong Hoon Lee/Young Chang Lim/Jung Gweon Lee
|
|
Abstract
|
|
|
Background and Objectives : Although various analgesics have been administrated for
postoperative pain control in outpatient nasal surgery, postoperative pain has not been
effectively controlled until now. Recently, Myprodol®, a combination
analgesics with codein, ibuprofen and paracetamol was developed and used as a new
analgesics. This study was performed to evaluate the effectiveness of
Myprodol® for postoperative pain control in outpatient nasal surgery.
Materials and Methods : We studied 40 cases of outpatient nasal surgery, which were
composed of 20 cases of septoplasty and 20 cases of ethmoidectomy. We classified 2
groups which consisted of 10 cases of septoplasty and 10 cases of ethmoidectomy
respectively. The tiapropenic arid 1 tablet were administrated three times per day for 2
days in the first group postoperatively. The Myprodol® 2 capsules were
administrated three times per day for 2 days in the second group postoperativey. We
evaluated the postoperative pain with Verbal Rating Fain Scores (VRP), Visual Analogue
Pain scores (VAS) and satisfactory stores to pain control.
Results : Overall, Myprodol®-administrated group showed statistically
significant better VRP and VAS than tiapropenic acid-administrated group. Satisfactory
scores to pain control was higher in Myprodol®-administrated group than
tiapropenic arid-administrated group, too.
Conclusion : We conclude that Myprodol® is an effective oral analgesics
for postoperative pain control in outpatient nasal surgery.
|
|
KEYWORD
|
|
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|